Several anti-IAV drugs are available and dozens are in development.
We developed method for analysis of immuno-modulating properties of anti-IAV agents.
Gemcitabine, but not SaliPhe, SNS-032 and obatoclax allowed activation of immune responses.
Gemcitabine may protect infected patients against co- and re-infections.